雜志介紹

Pharmacoeconomics-open雜志介紹

《Pharmacoeconomics-open》是一本以English為主的開放獲取國際優秀期刊，中文名稱藥物經濟學-開放，本刊主要出版、報道領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2，最新CiteScore 指數為3.5。

本刊近期中國學者發表的論文主要有：

• Impact of Extrapolation Model Choices on the Structural Uncertainty in Economic Evaluations for Cancer Immunotherapy: A Case Study of Checkmate 067

  Author: Shao, Taihang; Zhao, Mingye; Liang, Leyi; Shi, Lizheng; Tang, Wenxi

• Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer

  Author: Verhoek, Andre; Cheema, Parneet; Melosky, Barbara; Samson, Benoit; Shepherd, Frances A.; de Marinis, Filippo; John, Thomas; Wu, Yi-Long; Heeg, Bart; Van Dalfsen, Nadia; Bracke, Benjamin; Miranda, Miguel; Shaw, Simon; Moldaver, Daniel

• Economic Evaluation of Nivolumab Versus Docetaxel for the Treatment of Advanced Squamous and Non-squamous Non-small Cell Lung Cancer After Prior Chemotherapy in China

  Author: Hu, Shanlian; Tang, Zhiliu; Harrison, James P.; Hertel, Nadine; Penrod, John R.; May, Jessica R.; Juarez-Garcia, Ariadna; Holdgate, Orban

英文介紹

Pharmacoeconomics-open雜志英文介紹

pharmacoeconomics - Open Focuses On Applied Research On The Economic Implications And Health Outcomes Associated With Drugs, Devices And Other Healthcare Interventions. The Journal Includes, But Is Not Limited To, The Following Research Areas:economic Analysis Of Healthcare Interventionshealth Outcomes Researchcost-of-illness Studiesquality-of-life Studiesadditional Digital Features (including Animated Abstracts, Video Abstracts, Slide Decks, Audio Slides, Instructional Videos, Infographics, Podcasts And Animations) Can Be Published With Articles; These Are Designed To Increase The Visibility, Readership And Educational Value Of The Journal’s Content. In Addition, Articles Published In Pharmacoeconomics -open May Be Accompanied By Plain Language Summaries To Assist Readers Who Have Some Knowledge Of, But Not In-depth Expertise In, The Area To Understand Important Medical Advances.all Manuscripts Are Subject To Peer Review By International Experts. Letters To The Editor Are Welcomed And Will Be Considered For Publication.